Caracterização anestésica da nanoemulsão não lipídica de propofol
Anesthetic profile of a non-lipid propofol nanoemulsion
Roberto Takashi Sudo; Laura Bonfá; Margarete Manhães Trachez; Roberto Debom; Marisa D. R Rizzi; Gisele Zapata-Sudo
Resumo
Palavras-chave
Abstract
Keywords
References
Glen JB. Animal studies of the anesthetic activity of ICI 35-868. Br J Anaesth. 1980;52:731-742.
Rolly G, Versichelen L, Zubair NA. Use of ICI 35868 as an anesthetic induction agent. Acta Anaesth Belg. 1980;31:241-247.
Shao X, Li H, White PF. Bisulfite-containing propofol: is it a costeffective alternative to Diprivan for induction of anesthesia?. Anesth Analg. 2000;91:871-875.
Kay B, Rolly G. ICI35868: The effect of a change of formulation on the incidence of pain after intravenous injection. Acta Anesthesiol Belg. 1997;28:317-322.
Jones C. Fundamentals of emulsions. Am J Anesth. 2000;27(^sSuppl):12-15.
Egan TD. Target-controlled drug delivery: progress toward an intravenous "vaporizer" and automated anesthetic administration. Anesthesiology. 2003;99:1214-1219.
Sabsovich I, Rehman Z, Yunen J. Propofol infusion syndrome: a case of increasing morbidity with traumatic brain injury. Am J Crit Care. 2007;16:82-85.
Dubey PK, Kumar A. Pain on injection of lipid-free Propofol and Propofol emulsion containing medium-chain triglyceride: a comparative study. Anesth Analg. 2005;101:1060-1062.
Baker MT, Naguib M. Propofol: the challenges of formulation. Anesthesiology. 2005;103:860-876.
Abad-Santos F, Galvez-Mugica MA, Santos MA. Pharmacokinetics and pharmacodynamics of a single bolus of propofol 2% in healthy volunteers. J Clin Pharmacol. 2003;43:397-405.
Ando R, Watanabe C. Characteristics of propofol-evoked vascular pain in anaesthetized rats. Br J Anaesth. 2005;95:384-392.
Hart B. Diprivan: a change of formulation. Eur J Anesthesiol. 2000;17:71-73.
Rau J, Roizen MF, Michael F, Doenicke AW, O'Connor M, Strohschneider U. Propofol in a emulsion of long- and medium-chain triglycerides: the effect on pain. Anesth Analg. 2001;93:382-384.
Doenicke AW, Roizen MF, Rau J. Pharmacokinetics and pharmacodynamics of propofol in a new solvent. Anesth Analg. 1997;85:1399-1403.
Paul M, Dueck M, Kampe S. Pharmacological characteristics and side effects of a new galenic formulation of propofol witout soyabean oil. Anaesthesia. 2003;58:1056-1062.
Banaszczyk MG, Carlo AT, Milan V. Propofol phosphate, a waterdrug soluble propofol prodrug: in vivo evaluation. . .
Cooke A, Anderson A, Buchanan K. Water-soluble propofol analogues with intravenous anaesthetic activity. Bioorg Med Chem Lett. 2001;11:927-930.
Trapani A, Laquintana V, Lopedota A. Evaluation of new propofol aqueous solution for intravenous anesthesia. Int J Pharm. 2004;278:91-98.
Bielen SJ, Lysco GS, Cough WB. The effect of a cyclodextrin vehicle on the cardiovascular profile of propofol in rats. Anesth Analg. 1996;82:920-924.
Trapani G, Latrofa A, Franco M. Inclusion complexation of propofol with 2-hydroxypropyl-beta-cyclodextrin: physicochemical, nuclear magnetic resonance spectroscopic studies, and anesthetic properties in rat. J Pharm Sci. 1998;87:514-518.
Huang YW, Buerkle H, Lee TH. Effect of pretreatment with ketorolac on propofol injection pain. Acta Anaesthesiol Scand. 2002;46:1021-1024.
Iwama H, Nakane M, Ohmori S. Nafamostat mesilate, a kalicrein inhibitor, prevents pain on injection with propofol. Br J Anesth. 1998;81:963-964.
Ohmizo H, Obara S, Iwana H. Mechanism of injection pain with long and long-medium chain triglyceride emulsive propofol. Can J Anaesth. 2005;52:595-599.
Fujii Y, Nakayama M. A lidocaine/metoclopramide combination decreases pain on injection of propofol. Can J Anesth. 2005;52:474-477.
Doenick AW, Roizen MF, Rotzen MF. Reducing pain during propofol injection: the role of solvent. Anesth Analg. 1996;82:472-474.
Martinez V, Coutinho SV, Thakur S. Differential effects of chemical colonic irritation on behavioral pain response to intraperitoneal acetic acid in mice. Pain. 1999;81:179-186.